Investors
SEC Filings
Form 8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 02/27/2019
Document Outline
Entire Document (2081.5 KB)
Subdocument 1 - 8-K - FORM 8-K
Page 1 - UNITED STATES
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Subdocument 2 - EX-10.1 - EXHIBIT 10.1
Page 1 - Exhibit 10.1
Page 2 - Page
Page 3 - Table of Contents
Page 4 - Table of Contents
Page 5 - Table of Contents
Page 6 - Table of Contents
Page 7 - Table of Contents
Page 8 - EXHIBITS AND SCHEDULES
Page 9 - Senior Secured Superpriority Debtor-In-Possession Credit Agreement
Page 10 - Code. Any terms used in this Agreement that are defined in the Code shall be construed and defined a
Page 11 - Time References. Unless the context of this Agreement or any other Loan Document clearly requires ot
Page 12 - Funding of Borrowings. After receipt of a request for a Borrowing pursuant to Section 2.3(a), Agent
Page 13 - Independent Obligations. All Loans shall be made by the Lenders contemporaneously and in accordance
Page 14 - Apportionment and Application.
Page 15 - Termination of Commitments.
Page 16 - Prepayments.
Page 17 - Promise to Pay; Promissory Notes.
Page 18 - Interest Rates and Fees: Rates, Payments, and Calculations.
Page 19 - Crediting Payments. The receipt of any payment item by Agent shall not be required to be considered
Page 20 - LIBOR Election.
Page 21 - Special Provisions Applicable to LIBOR Rate.
Page 22 - N/A
Page 23 - Priority and Liens Applicable to the Company. The Borrower hereby covenants, represents and warrants
Page 24 - Incremental Loans.
Page 25 - CONDITIONS; TERM OF AGREEMENT.
Page 26 - Maturity. Subject to Section 9.1, this Agreement shall continue in full force and effect for a term
Page 27 - Due Organization and Qualification; Subsidiaries.
Page 28 - Governmental Consents. Subject to entry of the Interim DIP Order (or the Final DIP Order, when appli
Page 29 - Litigation.
Page 30 - Complete Disclosure. All factual information taken as a whole (other than forward-looking informatio
Page 31 - Payment of Taxes. Except as otherwise permitted under Section 5.5, all income and other material tax
Page 32 - Borrower as a Holding Company. Borrower is a holding company and does not have any material liabilit
Page 33 - [Reserved].
Page 34 - FDA Regulatory Compliance.
Page 35 - Material Contracts. Except for matters which, either individually or in the aggregate, could not rea
Page 36 - AFFIRMATIVE COVENANTS.
Page 37 - Taxes. In accordance with the Bankruptcy Code and subject to any required approval at the Bankruptcy
Page 38 - Compliance with Laws. Borrower will, and will cause each of its Subsidiaries to, comply with the req
Page 39 - Formation or Acquisition of Subsidiaries. Borrower will, at the time that any of its Subsidiaries fo
Page 40 - Zohydro Assets. Borrower shall ensure, and shall cause its Subsidiaries to ensure, at all times that
Page 41 - Compliance with Health Care Laws.
Page 42 - Use of Proceeds. Borrower shall, and shall cause its Subsidiaries to, use the proceeds of (i) the Cl
Page 43 - Assumption and Rejection of Contracts and Leases. Borrower shall provide reasonable advance notice t
Page 44 - Disposal of Assets. Other than Permitted Dispositions or transactions expressly permitted by Section
Page 45 - Restricted Payments. Borrower will not, and will not permit any of its Subsidiaries to make any Rest
Page 46 - Use of Proceeds. Borrower will not, and will not permit any of its Subsidiaries to, use the proceeds
Page 47 - Burdensome Agreements. Except as provided in the following sentence, each Loan Party will not, and e
Page 48 - Agent s Exercise of Rights and Remedies. Seek to enjoin, hinder, delay or object to the Agent s exer
Page 49 - EVENTS OF DEFAULT.
Page 50 - Voluntary Bankruptcy, etc. If an Insolvency Proceeding is commenced by any Subsidiary of the Borrowe
Page 51 - Loan Documents. The validity or enforceability of any Loan Document shall at any time for any reason
Page 52 - Modification to DIP Orders, Etc. If (i) an order of the Bankruptcy Court shall be entered reversing,
Page 53 - Actions Contrary to the Agreement. If any Loan Party or Subsidiary thereof shall file a motion or ot
Page 54 - Remedies Cumulative. The rights and remedies of the Lender Group under this Agreement, the other Loa
Page 55 - WITHOUT LIMITATION, THE FOREGOING INDEMNITY SHALL APPLY TO EACH INDEMNIFIED PERSON WITH RESPECT TO I
Page 56 - CHOICE OF LAW AND VENUE; JURY TRIAL WAIVER; JUDICIAL REFERENCE
Page 57 - PROVISION.
Page 58 - ASSIGNMENTS AND PARTICIPATIONS; SUCCESSORS.
Page 59 - N/A
Page 60 - N/A
Page 61 - Successors. This Agreement shall bind and inure to the benefit of the respective successors and assi
Page 62 - Replacement of Certain Lenders.
Page 63 - No Waivers; Cumulative Remedies. No failure by Agent or any Lender to exercise any right, remedy, or
Page 64 - Delegation of Duties. Agent may execute any of its duties under this Agreement or any other Loan Doc
Page 65 - Reliance by Agent. Agent shall be entitled to rely, and shall be fully protected in relying, and sha
Page 66 - Costs and Expenses; Indemnification. Agent may incur and pay Lender Group Expenses to the extent Age
Page 67 - Successor Agent. Agent may resign as Agent upon 30 days prior written notice to the Lenders (unless
Page 68 - N/A
Page 69 - Restrictions on Actions by Lenders; Sharing of Payments.
Page 70 - Concerning the Collateral and Related Loan Documents. Each member of the Lender Group authorizes and
Page 71 - Exemptions.
Page 72 - Refunds. If Agent or a Lender determines, in its sole discretion, that it has received a refund of a
Page 73 - Debtor-Creditor Relationship. The relationship between the Lenders and Agent, on the one hand, and t
Page 74 - N/A
Page 75 - Survival. All representations and warranties made by the Loan Parties in the Loan Documents and in t
Page 76 - IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed and delivered as of
Page 77 - N/A
Page 78 - N/A
Page 79 - N/A
Page 80 - Approved Budget
Page 81 - Pernix Therapeutics
Page 82 - Authorized Persons
Page 83 - N/A
Page 84 - Schedule D-1
Page 85 - A. Pernix Products
Page 86 - Schedule P-1
Page 87 - N/A
Page 88 - Schedule 1.1
Page 89 - N/A
Page 90 - N/A
Page 91 - N/A
Page 92 - N/A
Page 93 - N/A
Page 94 - N/A
Page 95 - N/A
Page 96 - N/A
Page 97 - N/A
Page 98 - N/A
Page 99 - N/A
Page 100 - N/A
Page 101 - N/A
Page 102 - N/A
Page 103 - N/A
Page 104 - N/A
Page 105 - N/A
Page 106 - N/A
Page 107 - N/A
Page 108 - N/A
Page 109 - N/A
Page 110 - N/A
Page 111 - N/A
Page 112 - N/A
Page 113 - N/A
Page 114 - N/A
Page 115 - N/A
Page 116 - N/A
Page 117 - N/A
Page 118 - N/A
Page 119 - N/A
Page 120 - N/A
Page 121 - N/A
Page 122 - N/A
Page 123 - Schedule 3.1
Page 124 - N/A
Page 125 - N/A
Page 126 - Schedule 3.2
Page 127 - N/A
Page 128 - Schedule 4.1(d)
Page 129 - Schedule 4.5
Page 130 - Cypress Pharmaceuticals, Inc.
Page 131 - Domain Names Relating to Cypress Pharmaceuticals, Inc.
Page 132 - Hawthorn Pharmaceuticals, Inc.
Page 133 - N/A
Page 134 - N/A
Page 135 - N/A
Page 136 - N/A
Page 137 - Pernix Ireland Limited
Page 138 - Pernix Ireland Pain Designated Activity Company
Page 139 - N/A
Page 140 - Pernix Therapeutics Holding, Inc.
Page 141 - N/A
Page 142 - IP Licenses
Page 143 - N/A
Page 144 - Schedule 4.6(b)
Page 145 - Schedule 4.11
Page 146 - Schedule 4.14
Page 147 - Schedule 4.15
Page 148 - Schedule 4.26
Page 149 - Schedule 4.29
Page 150 - N/A
Page 151 - N/A
Page 152 - N/A
Page 153 - N/A
Page 154 - Schedule 5.1
Page 155 - N/A
Page 156 - N/A
Page 157 - Schedule 5.18
Page 158 - Schedule 5.22
Page 159 - ASSIGNMENT AND ACCEPTANCE AGREEMENT ( Assignment Agreement ) is entered into as of _________________
Page 160 - N/A
Page 161 - N/A
Page 162 - N/A
Page 163 - EXHIBIT B-1
Page 164 - N/A
Page 165 - N/A
Page 166 - Agreement ), dated as of February 22, 2019, is entered into by and among the Obligors listed on the
Page 167 - Creditor Obligor has the meaning specified therefor in the definition of Subordinated Debt.
Page 168 - Insolvency Events ): (a) the Discharge of Senior Debt must have occurred before any Subordinated Deb
Page 169 - 2, 3, 4, and 5, any Subordinated Debt Payments shall be received in contravention of any such Sectio
Page 170 - N/A
Page 171 - N/A
Page 172 - Section 9 and Section 16 shall survive the Discharge of Senior Debt.
Page 173 - N/A
Page 174 - N/A
Page 175 - IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the date first writte
Page 176 - AGENT:
Page 177 - N/A
Page 178 - N/A
Page 179 - N/A
Page 180 - N/A
Page 181 - N/A
Page 182 - HEREBY FOUND AND CONCLUDED THAT:
Page 183 - N/A
Page 184 - 33 below, the Debtors acknowledge, admit, represent, stipulate and agree that:
Page 185 - N/A
Page 186 - N/A
Page 187 - N/A
Page 188 - N/A
Page 189 - N/A
Page 190 - N/A
Page 191 - N/A
Page 192 - N/A
Page 193 - N/A
Page 194 - N/A
Page 195 - N/A
Page 196 - N/A
Page 197 - N/A
Page 198 - N/A
Page 199 - N/A
Page 200 - N/A
Page 201 - N/A
Page 202 - N/A
Page 203 - N/A
Page 204 - N/A
Page 205 - N/A
Page 206 - N/A
Page 207 - N/A
Page 208 - N/A
Page 209 - N/A
Page 210 - N/A
Page 211 - N/A
Page 212 - N/A
Page 213 - N/A
Page 214 - N/A
Page 215 - N/A
Page 216 - N/A
Page 217 - N/A
Page 218 - N/A
Page 219 - N/A
Page 220 - N/A
Page 221 - N/A
Page 222 - N/A
Page 223 - N/A
Page 224 - N/A
Page 225 - N/A
Page 226 - N/A
Page 227 - N/A
Page 228 - N/A
Page 229 - N/A
Page 230 - N/A
Page 231 - N/A
Page 232 - N/A
Page 233 - N/A
Page 234 - N/A
Page 235 - N/A
Page 236 - N/A
Page 237 - N/A
Page 238 - N/A
Page 239 - N/A
Page 240 - [FORM OF] PROMISSORY NOTE
Page 241 - N/A
Page 242 - THIS NOTE SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAWS OF THE ST
Page 243 - N/A
Page 244 - February 22, 2019
Page 245 - N/A
Page 246 - N/A
Page 247 - N/A
Page 248 - Schedule 1(a)
Page 249 - Schedule 1(b)
Page 250 - Schedule 2
Page 251 - Schedule 3(a)
Page 252 - Schedule 3(b)
Page 253 - Schedule 4(a)
Page 254 - Schedule 4(b)
Page 255 - Schedule 4(c)
Page 256 - Schedule 4(d)
Page 257 - Schedule 5
Page 258 - Schedule 6
Page 259 - Schedule 7
Page 260 - Schedule 8
Page 261 - Schedule 9
Page 262 - Schedule 10
Page 263 - Schedule 11